• Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

  • 2024/09/18
  • 再生時間： 38 分
  • ポッドキャスト

Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
経済学
続きを読む 一部表示

Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbockerに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。